Literature DB >> 23511126

Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?

I Vorechovsky, A V Jones, N C P Cross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23511126     DOI： 10.1038/leu.2013.85

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  2 in total

Review 1.  Calreticulin (CALR) mutation in myeloproliferative neoplasms (MPNs).

Authors:  Wenyi Luo; Zhongxin Yu
Journal:  Stem Cell Investig       Date:  2015-08-31

2.  The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms.

Authors:  Zhiyuan Wu; Xinju Zhang; Xiao Xu; Yuming Chen; Tingting Hu; Zhihua Kang; Shibao Li; Hua Wang; Weiwei Liu; Xiaochao Ma; Ming Guan
Journal:  J Hematol Oncol       Date:  2014-07-15       Impact factor: 17.388
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.